000			02013 a2200577 4500
005			20250517170236.0
264		0	_c20180531
008			201805s 0 0 eng d
022			_a2092-6413
024	7		_a10.1038/emm.2017.114 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Chun-Yu
245	0	0	_aThe tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. _h[electronic resource]
260			_bExperimental & molecular medicine _c08 2017
300			_ae366 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProtein Tyrosine Phosphatase, Non-Receptor Type 6 _xgenetics
650	0	4	_aProtein-Tyrosine Kinases _xmetabolism
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aSTAT3 Transcription Factor _xgenetics
650	0	4	_aTriple Negative Breast Neoplasms _xdrug therapy
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aHuang, Tzu-Ting
700	1		_aChu, Pei-Yi
700	1		_aHuang, Chun-Teng
700	1		_aLee, Chia-Han
700	1		_aWang, Wan-Lun
700	1		_aLau, Ka-Yi
700	1		_aTsai, Wen-Chun
700	1		_aChao, Tzu-I
700	1		_aSu, Jung-Chen
700	1		_aChen, Ming-Huang
700	1		_aShiau, Chung-Wai
700	1		_aTseng, Ling-Ming
700	1		_aChen, Kuen-Feng
773	0		_tExperimental & molecular medicine _gvol. 49 _gno. 8 _gp. e366
856	4	0	_uhttps://doi.org/10.1038/emm.2017.114 _zAvailable from publisher's website
999			_c27455980 _d27455980